Prognostic Implications of MALAT1 and BACH1 Expression and Their Correlation with CTCs and Mo-MDSCs in Triple Negative Breast Cancer and Surgical Management Options

Table 10

Marker expression in both studied patients.

Types; Modified round block technique; (%)		Modified radical mastectomy; (%)	Total
+ve MALAT1	0 (0.0%)	27 (45%)	27 (36.4%)
+ve BACH1	0 (0.0%)	37 (61.7)	37 (50%)
-ve for both markers	14 (100%)	20 (33%)	34 (45.9%)